Effect of Immunization with Type 5 Group A Streptococcal Antigens and Liposaccharide (LPS) In Vivo and In Vitro on Splenic and Bone Marrow Multipotent Stromal Cells in Mice.
Yu F Gorskaya, T A Danilova, A I Tukhvatulin, A Sh Dzharullaeva, E N Semenova, L M Vavilova, E V Nagurskaya, V A Bekhalo, A G Minko, V G Nesterenko
{"title":"Effect of Immunization with Type 5 Group A Streptococcal Antigens and Liposaccharide (LPS) In Vivo and In Vitro on Splenic and Bone Marrow Multipotent Stromal Cells in Mice.","authors":"Yu F Gorskaya, T A Danilova, A I Tukhvatulin, A Sh Dzharullaeva, E N Semenova, L M Vavilova, E V Nagurskaya, V A Bekhalo, A G Minko, V G Nesterenko","doi":"10.1007/s10517-025-06352-8","DOIUrl":null,"url":null,"abstract":"<p><p>The number of multipotent stromal cells (MSC) in the splenic transplants of normal CBA mice in recipients immunized with inactivated type 5 group A streptococcal vaccine decreased by 3.5-1.8 times depending on the age of the recipients in comparison with that in the transplants grafted to the control recipients. Such immunization suppressed MSC transplantability, i.e., their potency to construct and maintain specific microenvironment of initial organs. In 24 h after administration of LPS to normal mice in vivo, the MSC content in the spleen and bone marrow increased by 1.8 and 1.6 times, respectively; in immunized mice, these parameters did not increase after LPS injection. The concentration of TNFα in the culture medium of bone marrow from normal mice increased pronouncedly after treatment with LPS both in vivo and in vitro (from 0 to 16.1±2.0 and to 14.2±0.1 pg/ml, respectively), while in the culture medium of bone marrow cells from of immunized mice, this cytokine was not detected after LPS treatment. Probably, immunization of mice with antigens of type 5 group A streptococci and resulting autoimmunity diminish animal sensitivity to LPS, which is reflected by examined parameters of the stromal tissue.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"437-441"},"PeriodicalIF":0.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-025-06352-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
The number of multipotent stromal cells (MSC) in the splenic transplants of normal CBA mice in recipients immunized with inactivated type 5 group A streptococcal vaccine decreased by 3.5-1.8 times depending on the age of the recipients in comparison with that in the transplants grafted to the control recipients. Such immunization suppressed MSC transplantability, i.e., their potency to construct and maintain specific microenvironment of initial organs. In 24 h after administration of LPS to normal mice in vivo, the MSC content in the spleen and bone marrow increased by 1.8 and 1.6 times, respectively; in immunized mice, these parameters did not increase after LPS injection. The concentration of TNFα in the culture medium of bone marrow from normal mice increased pronouncedly after treatment with LPS both in vivo and in vitro (from 0 to 16.1±2.0 and to 14.2±0.1 pg/ml, respectively), while in the culture medium of bone marrow cells from of immunized mice, this cytokine was not detected after LPS treatment. Probably, immunization of mice with antigens of type 5 group A streptococci and resulting autoimmunity diminish animal sensitivity to LPS, which is reflected by examined parameters of the stromal tissue.
期刊介绍:
Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005.
World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells.
The Russian Volume Year is published in English from April.